3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide has been researched along with dizocilpine maleate in 1 studies
| Studies (3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide) | Trials (3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide) | Recent Studies (post-2010) (3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide) | Studies (dizocilpine maleate) | Trials (dizocilpine maleate) | Recent Studies (post-2010) (dizocilpine maleate) |
|---|---|---|---|---|---|
| 14 | 0 | 6 | 7,741 | 9 | 1,449 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, D; Dyck, B; Guest, K; Johnson, R; Mishra, RK; Sookram, C | 1 |
1 other study(ies) available for 3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and dizocilpine maleate
| Article | Year |
|---|---|
PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schi
Topics: Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Drug Administration Schedule; Interpersonal Relations; Male; MSH Release-Inhibiting Hormone; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Social Behavior Disorders | 2011 |